Lack of ifn‐γ‐mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines
- 29 December 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 97 (4) , 501-507
Abstract
Downregulation of major histocompatibility complex (MHC) molecules by tumor cells impairs cellular immune recognition and contributes to inefficient cell‐mediated tumor eradication. Low or lack of expression of MHC molecules is frequently observed in early developmental or embryonically derived tumor cells. Considering the central role of the class II transactivator (CIITA) in MHC class II‐ and class I‐mediated antigen presentation, we compared the induction of CIITA by interferon‐γ (IFN‐γ) in a diverse panel of developmental and more differentiated tumor cell lines. In contrast to the more differentiated tumor cell lines, none of the developmental tumor cell lines were capable of expressing CIITA after treatment with IFN‐γ. Remarkably, in transient transfection assays, CIITA promoter IV (CIITA‐PIV) was found to be induced by IFN‐γ. Southern blot analysis of genomic DNA obtained from the developmental tumor cell lines indicated that the absence of endogenous CIITA induction was due to methylation of the CIITA‐PIV region. Exposure to 5‐azacytidine restored induction of CIITA and congruent HLA‐DRA expression in these cells. The observation that only developmental tumor cell lines, originating from various tissues, employ methylation to silence CIITA expression may reflect the natural status of CIITA expression during early development rather than oncogenic transformation.Keywords
This publication has 51 references indexed in Scilit:
- Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-γ inducible promoter (PIV) of CIITAHuman Immunology, 2000
- HLA-DR and β 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entitiesJournal of Clinical Pathology, 2000
- Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancerThe Journal of Pathology, 1999
- Activation of the MHC Class II Transactivator CIITA by Interferon-γ Requires Cooperative Interaction between Stat1 and USF-1Immunity, 1998
- Assembly of functional regulatory complexes on MHC class II promoters in vivoJournal of Molecular Biology, 1997
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- Selection for β2-microglobulin mutation in mismatch repair-defective colorectal carcinomasCurrent Biology, 1996
- Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITAScience, 1994
- Sequences and Factors: A Guide to MHC Class-II TranscriptionAnnual Review of Immunology, 1992
- Analysis of HLA antigens on germ cells in human semenEuropean Journal of Immunology, 1989